NEUROLEPTIC MALIGNANT SYNDROME

Neuroleptic malignant syndrome is a rare, idiosyncratic condition rela ted to neuroleptic use which may develop at any stage during neurolept ic treatment and can prove fatal Although most commonly seen in psychi atric patients, anyone prescribed a neuroleptic is at risk and it has been associated with other agents. This article discusses its recognit ion, risk factors, clinical course and treatment, together with a summ ary of current thinking on its aetiology.